A review of the trends of lymphomas in the equatorial belt of Africa

Hematological Oncology

Volumn 29, Issue 3, 2011, Pages 111-115

  Rogena, Emily A ^a,b   De Falco, Giulia ^a   Schurfeld, Karin ^a,c   Leoncini, Lorenzo ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF NAIROBI   (Kenya)

^c Pathologic Anatomy Asl8 ^*  (Italy)

Author keywords

Developing countries; Infectious agents; Lymphomas

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTINEOPLASTIC AGENT; HAIR DYE; HERBICIDE; PLANT EXTRACT;

AFRICA; ARBOVIRUS; B CELL LYMPHOMA; CANCER CLASSIFICATION; CANCER CONTROL; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; CHLAMYDOPHILA PSITTACI; CYTOKINE PRODUCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DRUG COST; EDUCATIONAL STATUS; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HEALTH CARE ACCESS; HEALTH CARE PLANNING; HEALTH PROGRAM; HELICOBACTER PYLORI; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DYSREGULATION; IMMUNOSTIMULATION; LYMPHOMA; LYMPHOMAGENESIS; MALARIA; NONHODGKIN LYMPHOMA; OCULAR ADNEXAL LYMPHOMA; OVERALL SURVIVAL; PATIENT COMPLIANCE; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; RISK FACTOR; SEX DIFFERENCE; SOCIOECONOMICS; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

AFRICA; FEMALE; HUMANS; LYMPHOMA; MALE; TREATMENT OUTCOME;

EID: 80052936721     PISSN: 02780232     EISSN: 10991069     Source Type: Journal    
DOI: 10.1002/hon.977     Document Type: Review

References (42)

1. World Health Organization Classification of Tumours: Tumours of Haematopoietic, Lymphoid tissues, Jaffe ES, Harris NL, Stein H, Vardimar JW (eds). IARC Press: Lyon, 2008; 262-264.
2. Grulich AE, Vajdic CM. The epidemiology of non-Hodgkin lymphoma. Pathology 2005; 37: 409-419.
3. Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006; 107: 265-276.
4. Rasti N, Falk KI, Donati D, et al. Circulating Epstein-Barr virus in children living in malaria-endemic areas. Scand J Immunol 2005; 61: 461-465.
5. Moormann AM, Chelimo K, Sumba OP, et al. Exposure to holoendemic malaria results in elevated Epstein-Barr virus loads in children. J Infect Dis 2005; 191: 1233-1238.
6. Mutalima N, Molyneux E, Jaffe H, et al. Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: results from a Case-Control Study..
7. Rainey JJ, Omenah D, Sumba PO. Spatial clustering of endemic Burkitt's lymphoma in high-risk regions of Kenya. Int J Cancer 2006; 120: 121-127.
8. Leoncini L, Raphael M, Stein H, et al. Burkitt Lymphoma. World Health Organization Classification of Tumours: Tumours of Haematopoietic and Lymphoid Tissues. In World Health Organization classification of tumours: tumours of haematopoietic and lymphoid tissues Jaffe ES, Harris NL, Stein H, Vardimar JW (eds). IARC Press: Lyon, 2008; 262-264.
9. Angeletti PC, Zhang L, Wood C. The viral etiology of AIDS-associated malignancies. Adv Pharmacol 2008; 56: 509-557.
10. Levine AM. AIDS-related lymphoma. Semin Oncol Nurs 2006; 22: 80-89.
11. Noy A. Update in HIV lymphoma. Curr Opin Oncol 2006; 18: 449-455.
12. Pantanowitz L, Schlecht HP, Dezube BJ. The growing problem of non-AIDS-defining malignancies in HIV. Curr Opin Oncol 2006; 18: 469-478.
13. Wood C, Harrington W Jr. AIDS and associated malignancies. Cell Res 2005; 15: 947-952.
14. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-1869.
15. Chang Y, Moore PS. Kaposi's sarcoma (KS)-associated herpesvirus and its role in KS. Infect Agents Dis 1996; 5: 215-222.
16. Ho M, Webster HK, Green B, Looareesuwan S, Kongchareon S, White NJ. Defective production of and response to IL-2 in acute human falciparum malaria. J Immunol 1998; 141: 2755-2759.
17. Westergaard T, Andersen PK, Pedersen JB, et al. Birth characteristics, sibling patterns, and acute leukemia risk in childhood: a population-based cohort study. J Natl Cancer Inst 1997; 89: 939-947.
18. Thiede C, Wündisch T, Alpen B, et al. German MALT Lymphoma Study Group. Persistance of monoclonal B Cells after eradication of H. pylori infection and complete histologic remission in gastric mucosa-associated lymphoid tissue B-cell lymphoma. J Clin Oncol 2001; 19: 1600-1609.
19. Decaudin D, de Cremoux P, Vincent-Salomon A, Dendale R, Lumbroso-Le Rouic L. Ocular adnexal lymphoma: a review of clinicopathological features and treatment options. Blood 2006; 108: 1451-1460.
20. Du MQ, Isaacson PG. Gastric MALT lymphomas: from aetiology to treatment. Lancet Oncol 2002; 3: 97-104.
21. Isaacson PG, Du MQ. MALT lymphoma: from morphology to molecules. Nat Rev Cancer 2004; 4: 644.
22. Akpek EK, Polcharoen W, Chan R, Foster CS. Ocular surface neoplasia masquerading as chronic blepharoconjunctivitis. Cornea 1999; 18: 282-288.
23. Mannami T, Yoshino T, Oshima K, et al. Clinical, histopathological, and immunogenetic analysis of ocular adnexal lymphoproliferative disorders: characterization of MALT lymphoma and reactive lymphoid hyperplasia. Mod Pathol 2001; 14: 641-649.
24. Lee DH, Sohn HW, Park SH, Kang YK. Bilateral conjunctival mucosa-associated lymphoid tissue lymphoma misdiagnosed as allergic conjunctivitis. Cornea 2001; 20: 427-429.
25. Ferreri AJ, Guidoboni M, Ponzoni M, et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphoma. J Natl Cancer Inst 2004; 96: 586-594.
26. Ferreri AJ, Ponzoni M, Guidoboni M, et al. Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy. J Clin Oncol 2005; 23: 5067-5073.
27. Ferreri AJ, Dolcetti R, Dognini GP, et al. Chlamydophila psittaci is viable and infectious in the conjubctiva and peripheral blood of patients with ocular adnexal lymphoma: results of a single-center prospective case-control study. Int J Cancer 2008; 123: 1089-1093.
28. Rosado MF, Byrne GE Jr, Ding F, et al. Ocular adnexal lymphoma: a clinicopathological study of a large cohort of patients with no evidence for an association with Chlamydia psittaci. Blood 2006; 107: 467-472.
29. Chanudet E, Zhou Y, Bacon CM, et al. Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions. J Pathol 2006; 209: 344-351.
30. Aigelsreiter A, Leitner E, Deutsch AJA, et al. Chlamydia psittaci in MALT lymphomas of ocular adnexals: the Austrian experience. Leukemia Res 2008, 32: 1292-1294.
31. Vargas RL, Fallone E, Felgar RE, et al. Is there an association between ocular adnexal lymphoma and infection with Chlamydia psittaci? The University of Rochester experience. Leukemia Res 2006; 30: 547-551.
32. Fisher SG, Fisher RI. The epidemiology of non-Hodgkins lymphoma. Oncogene 2004; 23: 6524-6534.
33. Glennhard AH, Maina TM. Reversing the trend of weak policy implementation in the Kenyan health sector - a study of budget allocation and spending of health resources versus set priorities. Policy system 2007; 5: 1478-4505.
34. Wamai RG. The Kenia Health System - analysis of the situation and enduring challenges. JMAJ 2009; 52: 134-140.
35. Emote CE, Enosolease ME. The effect of accessibility to drugs on the outcome of therapy in patients with malignant lymphoma. Niger Postgrad Med J 2008; 15: 10-14.
36. Stefan DC, Stones D, Dippenaar A, Kidd M. Ethnicity and the characteristics of Hodgkin lymphoma in children. Pediatr Blood Cancer 2009; 52: 153-154.
37. Neal RD, Allgar VL. Sociodemographic factors and delays in diagnosis of six cancers: analysis of data form the 'National survey of NHS Patients: cancer'. Br J cancer 2005; 92: 1971-1975.
38. Ribeiro RC, Pui CH. Saving the children - improving childhood cancer treatment in developing countries. N Engl J Med 2005; 352: 2158-2160.
39. Burton A. The UICC my child matters initiative awards: combating cancer in children in the developing world. Lancet Oncol 2006; 7: 13-14.
40. Ribeiro RC, Steliarova-Foucher E, Magrath I. Baseline status of paediatric oncology care in ten low-income or mid-income countries receiving My Child Matters Support: a descriptive study. Lancet Oncol (thelancet.com) 2008; 9: 721-729.
41. Orem J, Mbidde EK, Weiderpass E. Current investigations and treatment of Burkitt's lymphoma in Africa. Trop doct 2008; 38: 7-11.
42. Cavalli F. Cancer in the developing world: can we avoid the disaster? Nat clin pract oncol 2006; 3: 582-583.